Physician profile
Leon E Paulos
NPI 1992700330
$288,937.15
in general payments reported to CMS, 2019-2025
6 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $79K · 2021: $55K · 2022: $23K · 2023: $16K · 2024: $36K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $82K · Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $82,341.73 |
| Food and Beverage | $112.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $234,564.73 | 2019-2025 | Acufex Director |
| Stryker Corporation | $27,433.06 | 2019-2021 | |
| Anika Therapeutics, INC. | $13,646.51 | 2021-2025 | Nano, Pleuristik, Nano Fracture, Pleuristik, Nano Fracture, Ankle |
| Arthrosurface Incorporated | $8,566.75 | 2019-2025 | Nano Fx |
| Pacira Pharmaceuticals Incorporated | $4,613.53 | 2020 | |
| Medical Device Business Services, INC. | $112.57 | 2023 | Bristow Latarjet, Biointrafix, Healix Knotless Peek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Paulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.